Clinical Trial Update: Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating antiplatelet therapies with the Endeavor stent for intermediate duration in coronary artery disease; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Thrombosis

Snippet

Sponsor: Scripps Health | Conditions: Coronary Artery Disease, Coronary Thrombosis | Phase 4 | Status: COMPLETED